Vanda Pharmaceuticals (VNDA)

Jan 8, 2025, 4:17 PM EST - 9 days ago

Vanda's Letter to FDA Commissioner Highlights Faulty Gastroparesis NDA Review

Dec 20, 2024, 1:26 PM EST - 4 weeks ago

Vanda Pharmaceuticals: Net-Net Status Presents A Trading Opportunity

Dec 20, 2024, 9:13 AM EST - 4 weeks ago

Vanda Pharmaceuticals Announces Orphan Drug Designation Granted for VGT-1849A, a Novel and Selective Antisense Oligonucleotide Candidate for the Treatment of Polycythemia Vera

Dec 16, 2024, 9:29 PM EST - 4 weeks ago

Glancy Prongay & Murray LLP Announces Investigation of Vanda Pharmaceuticals Inc.

Nov 12, 2024, 4:58 PM EST - 2 months ago

Vanda Pharmaceuticals Announces Participation at November 2024 Investor Conferences

Nov 6, 2024, 8:20 PM EST - 2 months ago

Vanda Pharmaceuticals Inc. (VNDA) Q3 2024 Earnings Call Transcript

Nov 6, 2024, 4:02 PM EST - 2 months ago

Vanda Pharmaceuticals Reports Third Quarter 2024 Financial Results

Nov 1, 2024, 2:05 PM EDT - 2 months ago

Over 200% Stock Upside - Vanda Pharmaceuticals Undervalued With Robust Portfolio And Pipeline: Analyst

Oct 30, 2024, 4:30 PM EDT - 2 months ago

Vanda Pharmaceuticals to Announce Third Quarter 2024 Financial Results on November 6, 2024

Oct 14, 2024, 10:56 AM EDT - 3 months ago

Vanda Pharmaceuticals Confirms Receipt of Economically Identical Unsolicited, Non-Binding Proposal from Cycle Group Holdings Ltd.

Oct 14, 2024, 10:37 AM EDT - 3 months ago

Cycle Pharma maintains takeover offer for Vanda Pharmaceuticals

Oct 14, 2024, 8:19 AM EDT - 3 months ago

Cycle Pharmaceuticals Reaffirms All-Cash Proposal to Acquire Vanda Pharmaceuticals for $8.00 Per Share

Sep 19, 2024, 3:17 PM EDT - 4 months ago

Vanda Pharmaceuticals decries FDA's rejection of stomach paralysis drug as unjust

Sep 19, 2024, 10:33 AM EDT - 4 months ago

FDA Strikes Off Vanda Pharmaceuticals' Tradipitant For Stomach Paralysis, Asks For Additional Studies

Sep 19, 2024, 7:57 AM EDT - 4 months ago

U.S. FDA declines to approve Vanda's stomach paralysis drug

Sep 19, 2024, 7:00 AM EDT - 4 months ago

FDA Declines to Approve Vanda's Marketing Application for Tradipitant in Gastroparesis

Sep 11, 2024, 5:00 PM EDT - 4 months ago

Vanda Pharmaceuticals Announces Participation in the 2024 Cantor Global Healthcare Conference

Sep 4, 2024, 5:13 PM EDT - 4 months ago

Vanda Pharmaceuticals Announces Participation in the H.C. Wainwright Global Investment Conference

Aug 29, 2024, 4:30 PM EDT - 5 months ago

Vanda Pharmaceuticals Announces Participation in the Wells Fargo 2024 Healthcare Conference

Aug 8, 2024, 2:19 PM EDT - 5 months ago

Vanda Pharmaceuticals: I Believe That The Bidding War Is Not Over

Aug 2, 2024, 1:14 PM EDT - 6 months ago

Vanda Pharmaceuticals Inc. (VNDA) Q2 2024 Earnings Call Transcript

Jul 31, 2024, 4:01 PM EDT - 6 months ago

Vanda Pharmaceuticals Reports Second Quarter 2024 Financial Results

Jul 26, 2024, 9:19 AM EDT - 6 months ago

Vanda Pharmaceuticals to Announce Second Quarter 2024 Financial Results on July 31, 2024

Jul 1, 2024, 8:01 AM EDT - 7 months ago

Federal Court Allows Vanda's HETLIOZ® Patent Lawsuit to Proceed against Teva and Apotex

Jun 26, 2024, 6:27 PM EDT - 7 months ago

Future Pak withdraws offer to buy Vanda Pharmaceuticals

Jun 26, 2024, 5:37 PM EDT - 7 months ago

Future Pak Withdraws Proposal to Purchase Vanda Pharmaceuticals Inc.

Jun 20, 2024, 5:29 AM EDT - 7 months ago

Vanda Pharmaceuticals And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Jun 19, 2024, 9:40 PM EDT - 7 months ago

Vanda rejects Future Pak and Cycle Pharma's takeover offers

Jun 19, 2024, 8:48 PM EDT - 7 months ago

Vanda Pharmaceuticals Board of Directors Determines that Recent Unsolicited Takeover Proposals Are Not in the Best Interests of the Company and its Shareholders

Jun 17, 2024, 9:59 PM EDT - 7 months ago

Vanda Pharmaceuticals: Undervalued With Promising Pipeline And Acquisition Interest

Jun 13, 2024, 9:00 PM EDT - 7 months ago

Global Bipolar Disorder Market Size To Exceed USD 6.47 Billion By 2033 | CAGR Of 1.98%

Jun 13, 2024, 10:02 AM EDT - 7 months ago

Vanda Pharmaceuticals Confirms Receipt of Revised Unsolicited Takeover Proposal from Future Pak

Jun 13, 2024, 8:36 AM EDT - 7 months ago

Future Pak raises cash portion of buyout offer for Vanda

Jun 13, 2024, 8:15 AM EDT - 7 months ago

Future Pak Issues Enhanced and Final Proposal to Acquire Vanda Pharmaceuticals Inc.

Jun 10, 2024, 8:17 AM EDT - 7 months ago

CIONIC Unveils Three New Centers of Excellence on the East Coast to Aid Patient Mobility Through the Use of FDA-Cleared Bionic Clothing and Neuromodulation

ICCH

Jun 6, 2024, 9:24 AM EDT - 8 months ago

Vanda Pharmaceuticals Confirms Receipt of Unsolicited, Non-Binding Indication of Interest from Cycle Group Holdings Ltd.

Jun 6, 2024, 8:00 AM EDT - 8 months ago

Vanda Pharmaceuticals stock: why is it up 20% on Thursday?

Jun 6, 2024, 8:00 AM EDT - 8 months ago

Cycle Pharmaceuticals Announces All-Cash Proposal to Acquire Vanda Pharmaceuticals for $8.00 Per Share

May 31, 2024, 6:00 AM EDT - 8 months ago

Vanda Insights: Aramco share sale is not surprising

May 30, 2024, 5:20 PM EDT - 8 months ago

Vanda Pharmaceuticals Announces Participation in the Jefferies 2024 Global Healthcare Conference